What Shattuck Labs Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 1 |
| Sells | 0 | 6 |
| Total trades | 0 | 26 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 336,178 |
| Disposed | 0 | 118,901 |
| Net activity | +0 | +217,277 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Shukla Abhinav A. | Chief Technical Officer | Jul 06 | Exercise / conversion · M | +12,153 | $3.57 | +$43.4K | 98,533 |
| Shukla Abhinav A. | Chief Technical Officer | Jul 02 | Open-market sale · S | −410 | $7.01 | −$2.87K | 86,380 |
| Shukla Abhinav A. | Chief Technical Officer | Jul 02 | Exercise / conversion · M | +410 | $3.57 | +$1.46K | 86,790 |
| Shukla Abhinav A. | Chief Technical Officer | Jul 01 | Open-market sale · S | −100 | $7.07 | −$707 | 86,380 |
| Shukla Abhinav A. | Chief Technical Officer | Jul 01 | Exercise / conversion · M | +100 | $3.57 | +$357 | 86,480 |
| Shukla Abhinav A. | Chief Technical Officer | Jun 30 | Open-market sale · S | −23,365 | $7.08 | −$165K | 86,380 |
| Shukla Abhinav A. | Chief Technical Officer | Jun 30 | Exercise / conversion · M | +23,365 | $3.57 | +$83.4K | 109,745 |
| Pandite Arundathy N. | Chief Medical Officer | Jun 30 | Open-market sale · S | −30,000 | $7.01 | −$210K | 136,219 |
| Siegall Clay B | Director | Jun 09 | Open-market buy · P | +62,500 | $4.00 | +$250K | 318,608 |
| Siegall Clay B | Director | May 22 | Grant / award · A | +128,054 | $1.08 | +$139K | 256,108 |
| Shukla Abhinav A. | Chief Technical Officer | May 21 | Grant / award · A | +5,122 | $1.08 | +$5.56K | 86,380 |
| Stout Stephen | See Remarks | May 15 | Grant / award · A | +12,805 | $1.08 | +$13.9K | 93,366 |
| Schreiber Taylor | Chief Executive Officer | May 12 | Grant / award · A | +25,610 | $1.08 | +$27.8K | 122,222 |
| Pandite Arundathy N. | Chief Medical Officer | May 12 | Open-market sale · S | −30,000 | $6.61 | −$198K | 166,219 |
| Shukla Abhinav A. | Chief Technical Officer | May 12 | Open-market sale · S | −2,032 | $7.01 | −$14.2K | 81,258 |
| Shukla Abhinav A. | Chief Technical Officer | May 12 | Exercise / conversion · M | +2,032 | $3.57 | +$7.25K | 83,290 |
| Neill Andrew R | Chief Financial Officer | May 12 | Grant / award · A | +64,027 | $1.08 | +$69.4K | 292,251 |
| Stout Stephen | See Remarks | May 10 | Withheld — tax / exercise cost · F | −968 | $6.85 | −$6.63K | 80,561 |
| DeYoung Casi | Chief Business Officer | Jan 25 | Withheld — tax / exercise cost · F | −2,286 | $4.15 | −$9.49K | 73,480 |
| Neill Andrew R | Chief Financial Officer | Jan 25 | Withheld — tax / exercise cost · F | −2,589 | $4.15 | −$10.7K | 228,224 |
Loading...
